Bio-Rad Laboratories, Inc. (BIO)
NYSE - Nasdaq Real Time Price. Currency in USD
Add to watchlist
As of 03:34PM EDT. Market open.
Currency in USD
Valuation Measures4
| Market Cap (intraday) | 7.97B |
| Enterprise Value | 7.77B |
| Trailing P/E | N/A |
| Forward P/E | 25.06 |
| PEG Ratio (5 yr expected) | 1.07 |
| Price/Sales (ttm) | 3.05 |
| Price/Book (mrq) | 0.91 |
| Enterprise Value/Revenue | 2.91 |
| Enterprise Value/EBITDA | -11.86 |
Trading Information
Stock Price History
| Beta (5Y Monthly) | 0.88 |
| 52-Week Change 3 | -27.50% |
| S&P500 52-Week Change 3 | 22.43% |
| 52 Week High 3 | 431.79 |
| 52 Week Low 3 | 261.59 |
| 50-Day Moving Average 3 | 319.54 |
| 200-Day Moving Average 3 | 335.19 |
Share Statistics
| Avg Vol (3 month) 3 | 211.55k |
| Avg Vol (10 day) 3 | 239.19k |
| Shares Outstanding 5 | 23.42M |
| Implied Shares Outstanding 6 | 28.53M |
| Float 8 | 19.96M |
| % Held by Insiders 1 | 15.24% |
| % Held by Institutions 1 | 83.97% |
| Shares Short (Apr 15, 2024) 4 | 688.47k |
| Short Ratio (Apr 15, 2024) 4 | 3.77 |
| Short % of Float (Apr 15, 2024) 4 | 3.86% |
| Short % of Shares Outstanding (Apr 15, 2024) 4 | 2.41% |
| Shares Short (prior month Mar 15, 2024) 4 | 579.33k |
Dividends & Splits
| Forward Annual Dividend Rate 4 | N/A |
| Forward Annual Dividend Yield 4 | N/A |
| Trailing Annual Dividend Rate 3 | 0.00 |
| Trailing Annual Dividend Yield 3 | 0.00% |
| 5 Year Average Dividend Yield 4 | N/A |
| Payout Ratio 4 | 0.00% |
| Dividend Date 3 | N/A |
| Ex-Dividend Date 4 | N/A |
| Last Split Factor 2 | 2:1 |
| Last Split Date 3 | Mar 08, 2002 |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | Dec 31, 2023 |
| Most Recent Quarter (mrq) | Dec 31, 2023 |
Profitability
| Profit Margin | -23.86% |
| Operating Margin (ttm) | 14.24% |
Management Effectiveness
| Return on Assets (ttm) | 1.77% |
| Return on Equity (ttm) | -6.94% |
Income Statement
| Revenue (ttm) | 2.67B |
| Revenue Per Share (ttm) | 91.45 |
| Quarterly Revenue Growth (yoy) | -6.70% |
| Gross Profit (ttm) | N/A |
| EBITDA | 511.6M |
| Net Income Avi to Common (ttm) | -637.32M |
| Diluted EPS (ttm) | -21.81 |
| Quarterly Earnings Growth (yoy) | -57.80% |
Balance Sheet
| Total Cash (mrq) | 1.61B |
| Total Cash Per Share (mrq) | 56.35 |
| Total Debt (mrq) | 1.41B |
| Total Debt/Equity (mrq) | 16.08% |
| Current Ratio (mrq) | 5.83 |
| Book Value Per Share (mrq) | 306.51 |
Cash Flow Statement
| Operating Cash Flow (ttm) | 374.9M |
| Levered Free Cash Flow (ttm) | 170.82M |
© 2024 Yahoo. All rights reserved.